Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Rebecca S. Hock, PhD
JCP
Meta-Analysis
Rapidity of Improvement With Intranasal Esketamine for MDD
December 12, 2022
This meta-analysis found that augmenting antidepressants with intranasal esketamine vs placebo was more effective in reducing depression severity at 24 hours and study endpoint.
Rebecca S. Hock
,
Anna Feeney
,
Nadia Iovieno
, et al
JCP
Meta-Analysis
Vortioxetine for Major Depressive Disorder
June 15, 2021
Prior meta-analyses have found vortioxetine to be efficacious for depression. Building on those findings, the present meta-analysis examined the effect that placebo response has on drug-placebo effect size in...
Nadia Iovieno
,
George I. Papakostas
,
Anna Feeney
, et al
JCP
Meta-Analysis
Esketamine Augmentation in Major Depressive Disorder
May 26, 2020
The FDA has now approved intranasal esketamine as augmention in treatment-resistant depression, and recent studies of its efficacy have been encouraging. This meta-analysis synthesizes the evidence to provide an...
George I. Papakostas
,
Naji C. Salloum
,
Rebecca S. Hock
, et al
JCP
Original Research
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study
August 5, 2014
Yoichiro Takayanagi
,
Adam P. Spira
,
O. Joseph Bienvenu
, et al
